Rankings
▼
Calendar
SLDB Q1 2025 Earnings — Solid Biosciences Inc. Revenue & Financial Results | Market Cap Arena
SLDB
Solid Biosciences Inc.
$644M
Q1 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$407,000
Operating Income
-$40M
Net Income
-$39M
EPS (Diluted)
$-0.59
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$32M
Free Cash Flow
-$32M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$344M
Total Liabilities
$49M
Stockholders' Equity
$294M
Cash & Equivalents
$211M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$407,000
-$327,000
-24.5%
Operating Income
-$40M
-$27M
-49.1%
Net Income
-$39M
-$24M
-61.6%
← Q4 2024
All Quarters
Q2 2025 →